How much the cost of targeted therapy for ovarian cancer needs cannot be standardized, generally it needs 5,000~20,000 RMB, and the specific cost needs to be judged according to the region, hospital grade, condition, medical insurance policy and other factors.
Ovarian cancer is a malignant tumor originated from ovary, and targeted therapy is an effective method to treat ovarian cancer. At present, it is impossible to standardize the cost of ovarian cancer targeted therapy. Generally, it may need 5000~20000 RMB, and the specific cost mainly depends on factors such as the location, hospital grade, severity of disease, and whether it enters the medical insurance policy.
Targeted drugs for ovarian cancer are currently divided into two kinds, one is PARP inhibitor and the other is angiogenesis inhibitor such as bevacizumab, and the specific treatment plan is also different, so the cost of targeted therapy for ovarian cancer can not be generalized, and there are obvious individual differences.
All in all, the cost of targeted therapy for ovarian cancer is subject to the actual situation. Patients need to actively cooperate with doctors in treatment and use medication under doctors’ guidance. Strengthen daily life management and review on time.